. Indian startup PredOmix develops an AI-based blood test for detecting cancer that has a 98% accuracy rate. With OncoVeryx-F technology and metabolomics, PredOmix detects 32 cancers in one test. Clinical trials with thousands of participants can detect cancer earlier, improving treatment outcomes and saving lives. PredOmix has a mission to improve medical care through the universal access of basic medical resources.
Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?